New liquid biopsy technology can detect disease from a drop of blood

🇨🇳 Medical Xpress (CN) —

AI Summary

Researchers at Peking University have developed a liquid biopsy platform called 'cf-EpiTracing' capable of detecting and tracing diseases from as little as 50 μl of human plasma. The technology was published in Nature on March 4, 2026, and was led by professors from PKU's College of Future Technology and Department of Hematology. This innovation represents a significant advancement in non-invasive disease diagnostics.

An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing diseases from as little as 50 μl of human plasma, or roughly a drop of blood. The research, published in Nature on March 4, 2026, was led by Professor He Aibin from the College of Future Technology and Professor Jing Hongmei from the Department of Hematology, PKU Third Hospital.

Health AI & Tech liquid biopsy cf-EpiTracing disease detection Peking University medical research plasma diagnostics Nature journal

Read original source →